Showing 2431-2440 of 2652 results for "".
- MacuLogix Introduces the AdaptDx Pro Guided by Theiahttps://modernod.com/news/maculogix-introduces-the-adaptdx-pro-guided-by-theia/2477230/MacuLogix has introduced the AdaptDx Pro guided by Thei, a next generation dark adaptation functional testing. The company’s original AdaptDx automated dark adaptometer was introduced in 2014 and has since been used by more than 1,000 eye care professionals to identify and monitor AMD. The
- Improved Reimbursement for Endoscopic Cyclophotocoagulation (ECP) when Combined with Cataract Surgeryhttps://modernod.com/news/improved-reimbursement-for-endoscopic-cyclophotocoagulation-ecp-when-combined-with-cataract-surgery/2477219/Beaver-Visitec International (BVI) expressed support for two new CPT codes and improved reimbursement for ECP when combined with cataract surgery. Up to 1 in 5 patients [1] undergoing cataract extraction suffers from glaucoma, and ECP remains an important option for ophtha
- Aura Biosciences Appoints George Golumbeski, PhD, as Chairman of the Board of Directorshttps://modernod.com/news/aura-biosciences-appoints-george-golumbeski-phd-as-chairman-of-the-board-of-directors/2477212/Aura Biosciences announced the appointment of George Golumbeski, PhD, as Chairman of its Board of Directors. Dr. Golumbeski is a biopharmaceutical business leader with over 25 years of experience in the biotechnology industry. “George’s extensive experience will be invaluable to Aura as we
- Oxurion Reports Positive Topline Data From Phase 1 Study of THR-687 for Treatment of DMEhttps://modernod.com/news/oxurion-nv-reports-positive-topline-data-from-phase-1-study-evaluating-thr-687-for-treatment-of-dme/2477208/Oxurion has reported positive topline data from a phase 1 study with THR-687, a novel, potent, pan-RGD integrin antagonist for the treatment of diabetic macular edema (DME). The phase 1, open-label, multicenter, single dose escalation study evaluated the safety of a single intravitreal inj
- CooperVision Launches First Best Practices Scholarship Programhttps://modernod.com/news/coopervision-launches-first-best-practices-scholarship-program/2477193/To enable future eye care professionals to learn from some of the best in optometry, CooperVision announced the launch of its first “Best Practices Scholarship Program.” The scholarship—offered to third-year optometry students—is an expansion of the company’s annual Best Practices ini
- With EyeCare Partners Deal, Swiss Firm Sees a Base for ‘Organic Growth, Expansion and Consolidation’ of U.S. Vision Markethttps://modernod.com/news/with-eyecare-partners-deal-swiss-firm-sees-a-base-for-organic-growth-expansion-and-consolidation-of-u-s-vision-market/2477176/In the second major acquisition of an eyecare practice management group this year, the Switzerland-based Partners Group announced Monday morning that it has agreed to make a significant investment in EyeCare Partners LLC (ECP). FFL Partners announced separately that it was selling the stake it ha
- Genentech/Roche’s Faricimab Phase 3 Program Fully Recruited with Enrollment Completion of Wet AMD Clinical Trialshttps://modernod.com/news/genentech-roches-faricimab-phase-3-program-fully-recruited-with-enrollment-completion-of-wet-amd-clinical-trials/2477161/Genentech and Roche have completed patient enrollment in the TENAYA and LUCERNE phase 3 clinical trials investigating faricimab for the treatment of wet age-related macular degeneration (AMD). The phase 3 YOSEMITE and RHINE diabetic macular edema (DME) clinical trials completed patient enrollment
- Tom Frinzi to Retire; Warren Foust Appointed President of J&J Vision Surgicalhttps://modernod.com/news/tom-frinzi-to-retire-from-johnson-replaced-by-warren-foust/2477156/Johnson & Johnson Vision announced that Warren Foust will assume the role of Worldwide President, Surgical for Johnson & Johnson Vision, effective December 2. Mr. Foust replaces Tom Frinzi, who will retire at the end of 2019 after a 35-year career in ophthalmology. Mr. Frinzi was
- Eylea Injection Prefilled Syringe Now Availablehttps://modernod.com/news/eylea-injection-prefilled-syringe-now-available/2477154/Regeneron announced that the Eylea (aflibercept) prefilled syringe is now available for doctors to order. The 2 mg, single-dose, sterilized prefilled syringe provides physicians with a new way to administer Eylea that requires fewer preparation steps compared to vials. Eylea is the
- AAO and ASCRS Launch “Ophthovation” Joint Venture Business Innovation Conferenceshttps://modernod.com/news/aao-and-ascrs-launch-ophthovation-joint-venture-business-innovation-conferences/2477151/Two of the world’s largest ophthalmic organizations have finalized their joint venture “Ophthovation” to develop business conferences that accelerate innovation in ophthalmology. Called the Ophthovation Conference, the meeting will be held every year prior to the annual meetings of th